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Abstract. Background/Aim: Severe sepsis is associated with
high morbidity and mortality rates. Inflammation and
coagulation play pivotal roles in the pathogenesis of sepsis
leading to multiple organ failure, especially in the liver. The
aim of the present study was to assess the mechanism from
sepsis to liver damage in a mouse model. Materials and
Methods: We created a sepsis model by injecting
lipopolysaccharide (LPS) intraperitoneally in mice. At 0, 6,
12, and 24 h following intraperitoneal injection of LPS, mice
were euthanised and analyzed. Primary antibodies against
myeloperoxidase (MPO), hepatic sinusoidal endothelial cells
(SE-1), and P-selectin (CD62p) were used. Expression and
localization in neutrophil, sinusoidal endothelial, and
platelet cells were assessed by immunohistochemistry.
Results: Immunohistochemical analyses revealed a positive
staining for MPO, most abundantly in neutrophil
granulocytes, within the hepatic sinusoids immediately after
injection. Neutrophil extracellular trap (NET)-like structures
stained for MPO, indicating the presence of neutrophils
undergoing NETosis, were confirmed at 6 h after LPS
administration. SE-1 staining for liver sinusoidal endothelial
cells was significantly reduced at 12 h post-LPS
administration through sinusoidal endothelial injury or
detachment. Furthermore, the presence of extravasated
platelets was confirmed in the space of Disse at 24 h after
LPS administration. Blood sample analyses showed that
white blood cell counts and platelet counts decreased
gradually, while MPO amounts increased until 12 h after
LPS administration. Conclusion: We conclude that NET
formation and intravasated platelet aggregation are the first
steps from sepsis to liver damage, and that extravasated
platelet aggregation promoted by NET-facilitated detachment
of sinusoidal endothelial cells is the origin of sepsis-induced
liver dysfunction.
Sepsis is a clinical syndrome of systemic inflammatory
responses arising from an infectious process with a
presumed or known focus (1, 2). Severe sepsis, defined as
sepsis with acute organ dysfunction, is associated with high
morbidity and mortality rates (3). Inflammation and
coagulation play pivotal roles in the pathogenesis of sepsis
(4, 5). Sepsis-induced multiple organ failure (MOF) has
numerous causes, such as various types of shock, adult
respiratory distress syndrome (ARDS), and disseminated
intravascular coagulation (DIC) (6). Gando et al. (7)
reported that DIC is frequently associated with systemic
inflammatory response syndrome (SIRS; 83%) and that such
patients have a high mortality rate (63%). Ogura et al. (4)
evaluated coagulation activity, organ dysfunction, and SIRS
in critically-ill patients with thrombocytopenia and
examined the balance between coagulopathy and systemic
inflammation. In critically-ill patients with thrombo -
cytopenia, they found that coagulopathy and organ
dysfunction progressed with a significant mutual correlation,
depending on the increase in SIRS scores. Thus, SIRS-
associated coagulopathy may play a critical role in inducing
organ dysfunction after severe insult.
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Crosstalk between inflammation and coagulation is essential,
because coagulation can be activated by inflammation, as
observed in SIRS-associated coagulopathy (8). 
Previous studies showed that the generation of neutrophil
extracellular traps (NETs) is correlated with the severity of
organ dysfunction in sepsis (9, 10). Released extracellularly
from activated neutrophils in response to both infection and
the sterile inflammatory process, NETs are fibrous structures
that trap and kill pathogens within their matrices as part of
the host’s defence mechanism. The principal components of
NETs are DNA, granule protein myeloperoxidase (MPO),
nuclear protein high mobility group box 1 (HMGB1), and
histones, which cause endothelial damage when released
(11). It was recently reported that NETs induce the formation
of thrombi through a process termed immunothrombosis and
that this response helps to prevent the systemic dissemination
and tissue invasion of pathogens (12). Plasma from severely
septic patients induced Toll-like receptor 4 (TLR4)-
dependent platelet-neutrophil interactions, leading to the
production of NETs (13). However, the same research
demonstrated that NETs can deviate from the role of
infection control, namely that immunothrombosis can induce
damage to the host tissue through abnormal activation of the
coagulation and immune systems, which can lead to MOF
(14). In addition, NETs have components containing proteins
that lead to tissue and endothelial damage as damage-
associated molecular patterns (DAMPs) (15). 
However, the mechanism of organ dysfunction resulting
from sepsis is unclear. Shedding light on this mechanism
may reveal whether management of NET formation could be
a new therapeutic strategy for sepsis prevention.
The aim of the present study was to assess the mechanism
from sepsis to organ dysfunction in a mouse sepsis model.
Materials and Methods
Experimental animals. Animals were treated in accordance with the
Fundamental Guidelines for Proper Conduct of Animal Experiments
and Related Activities in Academic Research Institutions, under the
jurisdiction of the Ministry of Education, Culture, Sports, Science and
Technology of Japan. All animal experiments were approved by the
Committee on Animal Experimentation of Kanazawa University (AP
111868; Kanazawa, Japan). We used male BALB/c mice (aged 6-10
weeks; Charles River Laboratories, Kanagawa, Japan) as a sepsis
model to observe the effects of NETs and extravasated platelets.
Sepsis model. Lipopolysaccharide (LPS) (Sigma Chemical, St. Louis,
MO, USA) was dissolved in saline and diluted to 0.0003 g/ml. The
solution was administered at a rate of 1 mg/kg to each mouse
according to its mass and injected into the abdominal cavity.
Specimen extraction. At 0, 6, 12, and 24 h following intraperitoneal
injection of LPS, mice were administered isoflurane anaesthesia and
exsanguinated. Blood samples were collected and liver tissues were
removed after euthanasia.
Pathological assessment. Excised organs were washed with 10%
formalin. After fixation in 10% formalin solution for at least 24 h, the
liver was sliced into 3-mm sections and embedded in paraffin. Each
paraffin block was further sliced into 0.5-l-mm-thick sections and
mounted on slides. Some sections from each mouse were prepared for
histological analysis with hematoxylin and eosin (H&E) staining.
Immunohistochemistry. The remaining sections were immunostained
with anti-MPO antibody (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), anti-hepatic sinusoidal endothelial cell antibody (SE-1)
(Abcam, San Francisco, CA, USA), and anti-CD62p antibody
(Abcam, San Francisco, CA, USA). Deparaffinized sections were
pre-treated by autoclaving in 10% citric acid buffer (pH 8.0) at
120˚C for 15 min. Following treatment with protein block serum
(Dako Cytomation, Kyoto, Japan) for 10 min and incubation with
2% skim milk for 30 min to block nonspecific reactions, sections
were incubated with a primary antibody at 4˚C overnight. The
EnVision polymer solution (horseradish peroxidase; Dako
Cytomation) was then applied for 1 h. Signals were developed in
0.02% 3,3’-diaminobenzidine tetrahydrochloride solution containing
0.1% H2O2. Sections were lightly counterstained with hematoxylin
and examined using a fluorescence microscope (Olympus, Tokyo,
Japan). As negative controls, sections were incubated with
Tris(hydroxymethyl)aminomethane-buffered saline containing either
non-immune mouse IgG (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) or non-immune rabbit IgG (Santa Cruz Biotechnology,
Santa Cruz, CA, USA). Sections were then lightly counterstained
with hematoxylin and examined under the fluorescence microscope. 
Blood samples. Plasma samples were immediately separated from
the blood samples by centrifugation at 1,000 × g for 10 min. The
plasma samples were then frozen and stored at −80˚C until analysis.
White blood cell (WBC) and platelet (PLT) counts were measured
with an MEK-6458 (NIHON KODEN, Tokyo, Japan) using 500 μL
of sampled blood (n=6). Direct bilirubin (D-Bil), aspartate
aminotransferase (AST), and alanine aminotransferase (ALT) were
also evaluated (n=6).
Enzyme-linked immunosorbent assay (ELISA). The concentration of
MPO in the plasma was measured by ELISA using an MPO Mouse
ELISA Kit (Abcam, San Francisco, CA, USA) according to the
manufacturer’s instructions (n=6).
Statistical analysis. We investigated differences among the data by
one-way analysis of variance or two-sided Student’s t-test with the
SPSS 10.0 software package (SPSS, Chicago, IL, USA). Values of
p<0.05 were considered to indicate statistically significant differences.
Results
Immunohistochemical analysis for MPO expression.
Immunohistochemical analysis revealed positive staining for
MPO, which was most abundantly expressed in neutrophil
granulocytes, within the hepatic sinusoids immediately after
LPS injection (Figure 1A). NET-like structures stained for
MPO, indicating the presence of neutrophils undergoing
NETosis, were confirmed at 6 h post-LPS administration
(Figure 1B). This phenomenon was even more readily
apparent at 12 and 24 h (Figures 1C, D). 
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Hematoxylin-eosin staining. Liver sinusoids were lined with
fenestrated endothelial cells and flanked by plates of
hepatocytes in zone 3 immediately after LPS injection
(Figure 2A). However, sinusoidal dilatation and congestion
occurred in zone 3 at 12 h post-LPS injection (Figure 2B).
Immunohistochemical analysis for SE-1 expression. We
examined liver sinusoidal endothelial cells using SE-1 staining.
Endothelial cells were confirmed along the sinus immediately
after LPS injection (Figure 2C). However, staining was
significantly reduced at 12 h post-LPS injection through
sinusoidal endothelial injury or detachment (Figure 2D).
Immunohistochemical analysis for CD62p expression. We
examined the presence of platelets using CD62p staining.
CD62p is expressed in platelets and hepatic sinusoids
endothelial cells. Immediately following LPS administration,
CD62p expression was observed in hepatic sinusoid endothelial
cells, but not in platelets (Figure 2E). CD62p expression was
confirmed in the space of Disse at 24 h following LPS
administration, indicating platelet extravasation, but there was
no expression of CD62p in the hepatic sinusoidal endothelium
(Figure 2F).
Blood sample analysis: Changes in WBC, PLT, and MPO.
WBC, PLT, and MPO were quantified in blood samples
immediately after LPS administration, and at 6, 12, and 24 h
after LPS administration, and the change in each item was
compared with the initial value. The mean WBC count
immediately after LPS administration was 53×102/μl, followed
by a temporary decrease to 11×102/μl at 6 h (p<0.001), before
returning to 55×102/μl at 12 h post-LPS administration. No
significant difference was found between the latter value and
the value immediately after administration (p=0.412). At 24 h
post-LPS administration, the WBC count had marginally
decreased to 50×102/μl (p=0.037; Figure 3A). For the PLT
counts, the mean value was 61×104/μl immediately after LPS
administration, followed by gradual decreases to 51×104/μl at
6 h (p=0.030), 45×104/μl at 12 h (p<0.001), and 33×104/μl at
24 h (p<0.001; Figure 3B). Conversely, the mean MPO amount
was 16 ng/mL immediately after LPS administration, but
suddenly increased to 229 ng/mL at 6 h before peaking at 356
ng/mL at 12 h (p<0.001; Figure 3C).
Analysis for liver damage: Changes in AST, ALT, and D-Bil.
In this LPS-administered mouse model, we measured the
levels of AST, ALT, and D-Bil in blood samples. At 12 h, the
levels of AST, ALT, and D-Bil were all slightly elevated.
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Figure 1. Immunohistochemical analysis of MPO for shape changes after LPS administration in hepatic tissues. Immunostaining for MPO
immediately after LPS administration. Neutrophils are stained as spheres (A). Immunostaining for MPO at 6 h after LPS administration. Neutrophils
are stained in hepatic sinusoids as a moderately indistinct belt (B). Immunostaining for MPO at 12 h after LPS administration. Neutrophils are
stained in NET-like structures (C). Immunostaining for MPO at 24 h after LPS administration. Neutrophils are more clearly stained in NET-like
structures (D). Black arrows: MPO staining.
However, at 24 h, the levels were significantly elevated: AST
to a mean of 1133 IU/l (p<0.001), ALT to 935 IU/l
(p=0.002), and D-Bil to 0.145 mg/dL (p=0.004) compared
with the levels at 0 h (Table I).
Discussion
Severe sepsis is associated with high morbidity and mortality
rates. Inflammation and coagulation play pivotal roles in the
pathogenesis of sepsis (8). It has been thought that DIC is
characterized by the systemic activation of coagulation,
which results in generation and deposition of fibrin. In turn,
this process leads to microvascular thrombi in various
organs, significantly contributing to MOF (16). 
Neutrophils internalize pathogens through phagocytosis
(17). Bacteria are destroyed within phagosomes when
neutrophils’ various antimicrobial proteins are released, a
process called degranulation. However, independent of
phagocytic uptake, activation of neutrophils also releases
chromatin and granule proteins that together form extracellular
fibrillar matrices (18). Called NETs, these matrices degrade
virulence factors and bind, disarm, and kill Gram-positive and
Gram-negative bacteria (19). Through this active process of
trapping and killing pathogens, NETs play an important role
in host defence. However, recent reports have shown that
NETs also interact with platelets and leukocytes, and act as
three-dimensional frameworks for both deposition of fibrin
and later stabilization of thrombi (20). Subsequent platelet
in vivo 31: 1051-1058 (2017)
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Figure 2. H&E and immunohistochemical analysis for the presence and localization of platelet aggregation and sinusoidal endothelial disorder after
LPS administration. Liver sinusoids are lined with fenestrated endothelial cells and flanked by plates of hepatocytes in zone 3 immediately after LPS
injection. Black arrows: Normal sinusoid (A). Sinusoidal dilatation and congestion occur in zone 3 at 12 h post-LPS injection. White arrows: Dilated
sinusoid (B). Immunostaining with SE-1 immediately after LPS administration. Sinusoidal endothelial cells are stained (C). Immunostaining with SE-
1 at 12 h after LPS administration. Sinusoidal endothelial cells are not stained. Black arrows: Hepatic sinusoidal endothelial cells. White arrows:
Lack of SE-1 staining in zone 3 (D). Immunostaining for CD62p immediately after LPS administration. Sinusoidal endothelial cells are stained. Black
arrows: Hepatic sinusoidal endothelial cells (E). Immunostaining for CD62p at 24 h after LPS administration. Sinusoidal endothelial cells are not
stained, and platelets are aggregated in the space of Disse outside the sinusoids. White arrows: Extravasated platelets (F).
activation induces injury to the endothelium, leading to
thrombosis and impaired blood flow (21). Specifically,
activated platelets stimulate neutrophils to release NETs,
resulting in increased endothelial permeability (10, 22).
Other recent reports have shown that excessive formation
of NETs increases the risk of damage to the host (11). The
principal components of NETs are DNA, granule protein
MPO, nuclear protein HMGB1, and histones. Such proteins
risk causing tissue and endothelial damage as DAMPs (12,
23). Furthermore, this damage associated with NETs
contributes to denuding of the endothelium or loss of the
fenestrations and endothelial detachment (10, 11, 24). In the
liver tissue, sinusoidal endothelial cell damage allows
platelets to enter the space of Disse, which contains collagen
type 3 (24, 25). Within the space of Disse, platelets bind to
and form aggregates with the collagen type 3 (26). Such
platelet aggregation in the space of Disse has been termed
extravasated platelet aggregation. 
The present study revealed the process for sepsis-induced
liver damage from its point of origin with NETs and resultant
extravasated platelet aggregation. In this study,
immunohistochemical analysis revealed positive staining for
MPO, that is most abundantly expressed in neutrophil
granulocytes (27), within hepatic sinusoids immediately after
LPS injection. NET-like structures stained for MPO,
indicating the presence of neutrophils undergoing NETosis,
were confirmed at 6 h following LPS administration and
thereafter. Liver sinusoidal endothelial cells stained with SE-
1 were significantly reduced at 12 h post-LPS administration,
the result of denuding of the endothelium, loss of the
fenestrations, or endothelial detachment. Furthermore, the
presence of extravasated platelets was confirmed in the space
of Disse at 24 h following LPS administration.
As a consequence of unscheduled cell death, HMGB1 is
released with MPO, and represents a crucial signal in the
inflammatory response to tissue injury (28). To date, it has
Sakurai et al: Role for NETs in Early Sepsis
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Table I. Analysis for liver damage. 
                                    0 h                                         6 h                                          12 h                                          24 h                                    p-Value
AST                          71±5.0                                134.2±42.9                             358.5±178.0                           1135.0±220.5                             <0.001
ALT                         47.5±2.5                              149.2±98.5                              203.8±89.8                             935.5±141.5                               0.002
D-Bil                      0.03±0.01                            0.034±0.005                             0.048±0.01                             0.145±0.025                               0.004
Plasma samples from mice were assessed for liver ALT, AST, and D-Bil levels. At 24 h post-LPS administration, all levels were significantly
elevated. AST: Aspartate aminotransferase (IU/l); ALT: alanine aminotransferase (IU/l); D-Bil: direct bilirubin (mg/dl).
Figure 3. Sequential changes in blood sample values. At 6 h following LPS administration, decreases in WBC (A) and PLT (B) counts and an
increase in MPO amount (C) were confirmed. WBC: White blood cells (×102/μl); PLT: platelets (×104/μl); MPO: myeloperoxidase (ng/ml).
been thought that extracellular HMGB1 is a late mediator of
sepsis (29); however, it is also upregulated by activated
platelets in the early phase of sepsis (30). HMGB1 acts as
an early and late mediator of septic lethality. The early major
source of HMGB1 is derived from intravasated or
extravasated platelet aggregation, and the later source is
derived through the development of tissue injury.
In addition, by measuring the WBC and PLT counts in
peripheral blood, as well as the quantity of MPO, the present
study revealed a sudden decrease in WBC and an increase in
MPO at 6 h after LPS administration. These findings were
caused by rupture of neutrophils and subsequent release of
MPO leading to NET formation. It is thought that the WBC
count rose again temporarily because immature neutrophils
from bone marrow waiting to attack foreign intruders were
mobilized soon afterwards. Meanwhile, the PLT count
decreased gradually, reflecting the consumption of
intravasated or extravasated platelet aggregation.
It has been thought that organ dysfunction caused by sepsis
arises because DIC leads to microclots that occur
simultaneously and systemically (31). However, we must
consider the influence of extravasated platelet aggregation
wherein platelets adhere to the outside of blood vessels. In the
present study, the existence of extravasated platelet
aggregation in the liver was confirmed at 24 h following
intraperitoneal injection of LPS. Concurrently, the AST, ALT,
and D-Bil levels were also significantly elevated. The present
study revealed that the combination of NET and intravasated
platelet aggregation induced the early liver damage. 
In our previous study, we classified the progression from
sepsis to lung dysfunction (e.g. acute lung injury/ARDS) into
three phases, by characterizing the interactions between
neutrophils and platelets (10): Phase 1, NET formation and
intravasated platelet aggregation; Phase 2, extravasated
platelet aggregation, promoted by NET-facilitated
detachment of endothelial cells; and Phase 3, organ failure.
The present study on this phenomenon in the liver tended to
confirm our previous supposition with respect to liver
dysfunction arising from sepsis (Figure 4).
Regarding the promotion of liver damage, we suggest the
following: thromboxane A2 (TXA2) (32), vascular endothelial
growth factor-A (VEGF-A) (33), and 5-hydroxytryptamine 
(5-HT) (34) released from extravasated platelet aggregation
induce vasoconstriction in the liver’s central venules and lead
to portal hypertension (Figure 4). We also suggest the
possibility of matter exchange obstruction between sinusoids
and hepatocytes through the existence of platelets that have
leaked into the space of Disse.
In addition, the release of superabundant plasminogen
activator inhibitor-1 (PAI-1) (35) and transforming growth
factor-β (TGF-β) (36) from platelets leads to plasmin activity
inhibition and fibrinolysis, which are both involved in the
development of liver failure.
Recently, a new phenotype of MOF has emerged: persistent
inflammatory, immunosuppressed, catabolic syndrome (PICS).
It is well known that TGF-β and VEGF-A are potent
immunosuppressive factors that drive the expansion of
regulatory T-cells and myeloid-derived suppressor cells (37).
Moreover, platelets also contain proteins such as
thrombospondin-1 (TSP-1) and CD40L. TSP-1 is a potent
suppressor of T-cell activation via its receptor CD47 (38). The
CD40–CD40L co-stimulatory pathway has been shown to play
a crucial role in the production of cytokines, including
interleukin (IL)-10, a known immunosuppressive cytokine that
inhibits macrophage-dependent antigen presentation, T-cell
proliferation, and Th1 cytokine secretion of IL-2, interferon-γ,
and tumor necrosis factor-α (39). We suggest that the release
of s-CD40L, TSP-1, and VEGF-A by the surface membrane of
activated platelets leads to a state of immunoparalysis (Figure
4). Therefore, we consider that extravasated platelet
aggregation plays an essential role in the progression of PICS.
We conclude that NET formation and intravasated platelet
aggregation comprise the first steps from sepsis to liver
dysfunction. We further conclude that extravasated platelet
aggregation promoted by NET-facilitated detachment of
sinusoidal endothelial cells is most likely the origin of
sepsis-induced liver dysfunction.
In the initial management of sepsis, treatment basics
should first and foremost include a reduction in the release
in vivo 31: 1051-1058 (2017)
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Figure 4. Mechanism for the progression from sepsis to liver dysfunction,
characterized by neutrophil extracellular traps (NETs) and platelet
aggregation. Extravasated platelet aggregation in the space of Disse,
initiated by damage to the endothelium, is induced by the formation of
NETs or intravasated platelet aggregation in sepsis. Various growth
factors released by extravasated platelet aggregation, including TXA2, 5-
HT, PAI-1, and TGF-β, induce portal hypertension and promote the
progression of liver fibrosis. Furthermore, EPA-derived VEGF-A, TSP-1,
s-CD40L, and TGF-β may also contribute to immunoparalysis.
of surplus NETs, reduction in platelet aggregation, and
protection of the blood vessel endothelium. Moreover,
inhibition of platelet activation will reduce NET release and
tissue injury. It goes without saying that it is vital to
investigate and treat sepsis early to prevent its progression
to Phase II and Phase III.
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